CIK 0001574235
- Non-accelerated filer
- Smaller reporting company
Pulmatrix, Inc.
Sign in to watch- Ticker
- PULM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461821392
- Phone
- +1 888-355-4440
- Business address
- 945 CONCORD STREET, SUITE 1217, FRAMINGHAM, MA, 01701
- Former names
- Ruthigen, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −1,771 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +1,771 | 1,771 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −111 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +111 | 111 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −880 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +880 | 880 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −440 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +440 | 440 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −12,400 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +12,400 | 12,400 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-04-02 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-01-09 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-05-16 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-05 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +124,000 | 124,000 |
Page 1 of 2 · 31 trades